Fine needle aspiration biopsy in low‐ and middle‐income countries

Abstract

Fine needle aspiration biopsy (FNAB) in low‐ and middle‐income countries (LMIC), can provide minimally invasive, cost‐effective tissue diagnosis with rapid assessment and specimen triage, which is advantageous in these resource‐limited settings. Nevertheless, challenges such as equipment shortages, reagents, and lack of trained personnel exist. This article discusses the effectiveness of FNAB for diagnosis of malignant and inflammatory conditions across various organs, such as lymph nodes, breast, soft tissue, and thyroid and advocates for increased training opportunities and collaboration with academic centers to enhance diagnostic accuracy and access to pathology services.